Anti-CD20 (rituximab biosimilar) (MS4A1)
Figure-1: HEK293 cell line transfected with irrelevant protein (B) and human CD20 (A) were surface stained with anti-CD20 neutralizing antibody 1μg/ml (rituximab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.
Roll over image to zoom in
Shipping Info:
For estimated delivery dates, please contact us at support@abeomics.com
| Format : | Purified |
| Amount : | 100 µg |
| Purification : | Purified from cell culture supernatant by affinity chromatography. |
| Content : | Preservative: 0.1% Procline 300. Constituents: 50% Glycerol; PBS, pH 7.4; 0.1% BSA |
| Storage condition : | Store at -20°C (Avoid repeated freezing and thawing). |
Reconstitute with deionized water. Flow Cyt 1:100
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
![Sars-Cov-2 Spike Glycoprotein S1 Receptor Binding Domain [RBD] (319-541 aa)](https://s3-us-west-2.amazonaws.com/abeomics/templates/abeomics/images/noimage.jpg "Sars-Cov-2 Spike Glycoprotein S1 Receptor Binding Domain [RBD] (319-541 aa)")
